FAST NEWS: Livzon Pharma cancels repurchased H shares
The Latest: Livzon Pharmaceutical Group Inc. (1513.HK) announced on Friday that as of Jun. 27, 2024, it has repurchased a cumulative total of 2.78 million H shares, and all of which…
FAST NEWS: Livzon Pharma plans spinoff for reagent business
The latest: Livzon Pharmaceutical Group Inc. (1513.HK) announced on Friday it plans to spin off its Livzon Diagnostics unit, a diagnostic reagent and equipment manufacturer in which it holds a…
Recent Articles
RELATED ARTICLES
-
CSPC Pharma weighs up diet drug for bigger bottom line
1093.HK - IPO-bound Guofu stuck at low end of hydrogen-power food chain
-
Yum China revs up restaurant expansion, share repurchases
9987.HK YUMC.US
-
GigaCloud’s business shines, but investors still rain on its parade
GCT.US
-
Fanhua seeks support in share buyback as global expansion stalls
FANH.US HPH.US
